Close Menu

NEW YORK ─ ClinSpec Diagnostics said on Monday that it closed a £2.4 million ($3.1 million) financing round to support the further development of a blood test that uses infrared spectroscopy and artificial intelligence to detect early-stage cancers in minutes.

Its blood test also has the potential to indicate the type and severity of a tumor, allowing doctors and clinicians to prioritize and fast-track the most appropriate and effective treatments, ClinSpec said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.